SARS-Cov2 Clinical Diagnostics: Academic Scientists Take on the COVID-19 Pandemic [0.03%]
对抗COVID-19大流行：学术科学家参与SARS-CoV2临床诊断
Fyodor Urnov
Fyodor Urnov
In this issue of Med, Vanuytsel and colleagues1 demonstrate how academic institutions are stepping up to the forefront of SARS-CoV-2 testing by rapidly implementing a COVID-19 diagnostic test at a large safety net hospital serving an at-ris...
Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19 [0.03%]
羟氯喹对新冠病毒美国退伍军人住院患者的疗效研究
Joseph Magagnoli,Siddharth Narendran,Felipe Pereira et al.
Joseph Magagnoli et al.
Background: Despite limited and conflicting evidence, hydroxychloroquine, alone or in combination with azithromycin, is widely used in COVID-19 therapy. M...
What Is the Best Drug to Treat COVID-19? The Need for Randomized Controlled Trials [0.03%]
治疗新冠肺炎的最佳药物是什么？需要随机对照试验
Silvia Ottaviani,Justin Stebbing
Silvia Ottaviani
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently the biggest public health challenge to the biomedical community of the last century. Despite multiple public health measures,1, 2, 3 there remains an urgent need ...
Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial [0.03%]
洛匹那韦/利托那韦或阿比多尔在轻中型COVID-19成年患者中的疗效和安全性：探索性随机对照试验
Yueping Li,Zhiwei Xie,Weiyin Lin et al.
Yueping Li et al.
Background: Antiviral therapies against the novel coronavirus SARS-CoV-2, which has caused a global pandemic of respiratory illness called COVID-19, are still lacking. ...
Randomized Controlled Trial
Med (New York, N.Y.). 2020 Dec 18;1(1):105-113.e4. DOI:10.1016/j.medj.2020.04.001 2020
Validation of Predictors of Disease Severity and Outcomes in COVID-19 Patients: A Descriptive and Retrospective Study [0.03%]
验证COVID-19患者疾病严重程度和结果的预测指标：一项描述性和回顾性研究
Li Tan,Xia Kang,Xinran Ji et al.
Li Tan et al.
Background: The severity and outcome of COVID-19 cases has been associated with the percentage of circulating lymphocytes (LYM%), levels of C-reactive protein (CRP), interleukin-6 (IL-6), procalcitonin (PCT), lactic acid ...
Rapid Implementation of a SARS-CoV-2 Diagnostic Quantitative Real-Time PCR Test with Emergency Use Authorization at a Large Academic Safety Net Hospital [0.03%]
大型学术安全网医院快速实施具有紧急使用授权的SARS-CoV-2诊断实时定量PCR测试
Kim Vanuytsel,Aditya Mithal,Richard M Giadone et al.
Kim Vanuytsel et al.
Background: Significant delays in the rapid development and distribution of diagnostic testing for SARS-CoV-2 (COVID-19) infection have prevented adequate public health management of the disease, impacting the timely mapp...
Q&A with Lin Shen [0.03%]
林沈专访
Professor Lin Shen, MD, graduated from Xuzhou Medical College in 1984 and Beijing Medical University in 1995. She trained at the US National Institutes of Health in 2000, focusing on therapies for gastrointestinal tumors. Currently, she is ...
Always more immunotherapy in the management of B-lineage acute lymphoblastic leukemia [0.03%]
B系急性淋巴细胞白血病免疫治疗的进一步管理
In the FELIX study,1 the CAR-T product obecabtagene autoleucel (obe-cel) was investigated in relapsed/refractory adult B-cell lymphoblastic leukemia (B-ALL). The high responses associated with the low incidence of grade ≥3 side effects mak...